We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sucampo Pharmaceuticals, Inc. (delisted) | NASDAQ:SCMP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.00 | 18.00 | 18.00 | 0 | 01:00:00 |
From May 2019 to May 2024
By Ian Walker
LONDON--The soon-to-be-demerged pharmaceuticals unit of Reckitt Benckiser Group PLC (RB.LN) has appointed Cary J. Claiborne as Chief Financial Officer.
Reckitt Benckiser Pharmaceuticals, which is expected to be called Indivior PLC when it lists on the London Stock Exchange this year, said Mr. Claiborne was previously Chief Financial Officer of Sucampo Pharmaceuticals Inc. (SCMP). He has also held senior positions at New Generation Biofuels, Osiris Therapeutics, Constellation Energy, Home Depot Corporation, MCI and General Electric.
The consumer goods company, whose brands include Calgon, Finish, Dettol and Durex, said in July that it planned to demerge the unit and float it as a separately listed company, ending months of speculation as to its fate. Last month, it said it expected this to be completed this year,
Write to Ian Walker at ian.walker@wsj.com; @IanWalk40289749
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Sucampo Pharmaceuticals, Inc. (delisted) Chart |
1 Month Sucampo Pharmaceuticals, Inc. (delisted) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
